Market Cap (In CNY)
12.71 Billion
Revenue (In CNY)
1 Billion
Net Income (In CNY)
363.72 Million
Avg. Volume
3.26 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 16.08-25.58
- PE
- -
- EPS
- -
- Beta Value
- 0.7
- ISIN
- CNE1000043J1
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Mr. Lizhong Dai
- Employee Count
- -
- Website
- https://www.sansure.com.cn
- Ipo Date
- 2020-08-28
- Details
- Sansure Biotech Inc. develops and sells upstream nucleic acid extraction kits, real time PCR diagnostic and research kits, and fluorescence systems in China and internationally. The company offers novel coronavirus nucleic acid diagnostic kits; viral hepatitis and AIDS, blood screening, and extraction kits; cancer-related biomarkers; and kits for respiratory tract diseases, STDs, digestive tract diseases, prenatal and postnatal care, and genetic diseases, as well as instruments and other consumables. It serves hospitals and laboratories. The company was founded in 2008 and is based in Changsha, China.
More Stocks
-
7608SK Japan Co.,Ltd.
7608
-
1258
-
RYSMF
-
600768
-
RISHILASERishi Laser Limited
RISHILASE
-
GULFPETROGP Petroleums Limited
GULFPETRO
-
ICICIGI
-
034590Incheon City Gas Co., Ltd.
034590